814
Views
47
CrossRef citations to date
0
Altmetric
Review

Continuous positive airway pressure therapy in obstuctive sleep apnea: benefits and alternatives

, &
Pages 259-272 | Received 30 May 2016, Accepted 09 Mar 2017, Published online: 17 Mar 2017

References

  • Sullivan CE, Issa FB, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(825):862–865.
  • Quan SF, Howard BV, Iber C, et al. The sleep heart health study: design, rationale, and methods. Sleep. 1997;20(12):1077–1085.
  • Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–1235.
  • Gottlieb DJ, Whitney CW, Bonekat WH, et al. Relation of sleepiness to respiratory disturbance index: the sleep heart health study. Am J Respir Crit Care Med. 1999;159(2):502–507.
  • Young T. Rationale, design and findings of the Wisconsin sleep cohort study: toward understanding the total societal burden of sleep disordered breathing. Sleep Med Clin. 2009;4(1):37–46.
  • Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994;343(8897):572–575.
  • Giles TL, Lasserson TJ, Smith B, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001106. DOI:10.1002/14651858.CD001106.pub3.
  • Antic NA, Catcheside P, Buchan C, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep. 2011;34(1):111–119.
  • Antonopoulos CN, Sergentanis TN, Daskalopoulou SS, et al. Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: a meta-analysis. Sleep Med Rev. 2011;15(5):301–310.
  • Rizzi CF, Ferraz MB, Poyares D, et al. Quality adjusted life years gain and health status in patients with OSAS after one year of continuous positive airway pressure use. Sleep. 2014;37:1963–1968.
  • MartínezGarcía MÁ, Chiner E, Hernández L, et al. Spanish sleep network. Obstructive sleep apnoea in the elderly: role of continuous positive airway pressure treatment. Eur Respir J. 2015;46(1):14251.
  • Ferini-Strambi L, Baietto C, Di Gioia MR, et al. Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain Res Bull. 2003;61(1):8792.
  • Stranks EK, Crowe SF. The cognitive effects of obstructive sleep apnea: an updated meta-analysis. Arch Clin Neuropsychol. 2016;31(2):18693.
  • Kushida CA, Nichols DA, Holmes TH, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep. 2012;35(12):1593–1602.
  • Olaithe M, Bucks RS. Executive dysfunction in OSA before and after treatment: a meta-analysis. Sleep. 2013;36(9):1297–1305.
  • Kamba M, Suto Y, Ohta Y, et al. Cerebral metabolism in sleep apnea. Evaluation by magnetic resonance spectroscopy. Am J Respir Crit Care Med. 1997;156(1):296–298.
  • Canessa N, Castronovo V, Cappa SF, et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183(10):1419–1426.
  • Ferini-Strambi L, Marelli S, Galbiati A, et al. Effects of continuous positive airway pressure on cognition and neuroimaging data in sleep apnea. Int J Psychophysiol. 2013;89(2):203–212.
  • Placidi F, Diomedi M, Cupini LM, et al. Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome. J Sleep Res. 1998;7(4):288–292.
  • Prilipko O, Huynh N, Thomason ME, et al. An fMRI study of cerebrovascular reactivity and perfusion in obstructive sleep apnea patients before and after CPAP treatment. Sleep Med. 2014;15(8):892–898.
  • Dalmases M, SoléPadullés C, Torres M, et al. Effect of CPAP on cognition, brain function, and structure among elderly patients with OSA: a randomized pilot study. Chest. 2015;148(5):1214–1223.
  • Castronovo V, Canessa N, Strambi LF, et al. Brain activation changes before and after PAP treatment in obstructive sleep apnea. Sleep. 2009;32(9):1161–1172.
  • Ayalon L, Ancoli-Israel S, Drummond SP. Altered brain activation during response inhibition in obstructive sleep apnea. J Sleep Res. 2009;18(2):204–208.
  • Ayalon L, Ancoli-Israel S, Aka AA, et al. Relationship between obstructive sleep apnea severity and brain activation during a sustained attention task. Sleep. 2009;32:373–381.
  • Archbold KH, Borghesani PR, Mahurin RK, et al. Neural activation patterns during working memory tasks and OSA disease severity: preliminary findings. J Clin Sleep Med. 2009;5(1):21–27.
  • Toro R, Fox PT, Paus T. Functional co-activation map of the human brain. Cereb Cortex. 2008;18(11):2553–2559.
  • Corbetta M, Shulman GL. Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci. 2002;3(3):201–215.
  • Fox MD, Snyder AZ, Vincent JL, et al. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA. 2005;102(27):9673–9678.
  • Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1–38.
  • Raichle ME, MacLeod AM, Snyder AZ, et al. A default mode of brain function. Proc Natl Acad Sci USA. 2001;98:676–682.
  • Gusnard DA, Raichle ME. Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci. 2001;2(10):685–694.
  • Prilipko O, Huynh N, Schwartz S, et al. The effects of CPAP treatment on task positive and default mode networks in obstructive sleep apnea patient. An Fmri Study Plos One. 2012;7(12):e47433.
  • O’Donoghue FJ, Wellard RM, Rochford PD, et al. Magnetic resonance spectroscopy and neurocognitive dysfunction in obstructive sleep apnea before and after CPAP treatment. Sleep. 2012;35(1):41–48.
  • Morrell MJ, McRobbie DW, Quest RA, et al. Changes in brain morphology associated with obstructive sleep apnea. Sleep Med. 2003;4(5):451–454.
  • Torelli F, Moscufo N, Garreffa G, et al. Cognitive profile and brain morphological changes in obstructive sleep apnea. Neuroimage. 2011;54(2):787–793.
  • Bartlett DJ, Rae C, Thompson CH, et al. Hippocampal area metabolites relate to severity and cognitive function in obstructive sleep apnea. Sleep Med. 2004;5(6):593–596.
  • Demeter E, Hernandez-Garcia L, Sarter M, et al. Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage. 2011;54(2):1518–1529.
  • Fan J, McCandliss BD, Fossella J, et al. The activation of attentional networks. Neuroimage. 2005;26(2):471–479.
  • Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046–1053.
  • Buchner NJ, Sanner BM, Borgel J, et al. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007;176(12):1274–1280.
  • Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–1384.
  • Martinez-Garcia MA, Capote F, Campos-Rodriquez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407–2415.
  • Thunström E, Manhem K, Rosegren A, et al. Blood pressure response to losartan and continuous positive airway pressure in hypertension and obstructive sleep apnea. Am J Respir Crit Care Med. 2016;193(3):310–320.
  • Mokhlesi B, Hagen EW, Finn LA, et al. Obstructive sleep apnoea during REM sleep and incident non-dipping of nocturnal blood pressure: a longitudinal analysis of the Wisconsin sleep cohort. Thorax. 2015;70:1062–1069.
  • Gottlieb DJ, Punjabi NM, Mehra R, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014;370(24):2276–2285.
  • Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307(20):2161–2168.
  • Bratton DJ, Stradling JR, Barbe F, et al. Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomized controlled trials. Thorax. 2014;69(12):1128–1135.
  • Sánches-de-la-Torre M, Khalyfa A, Sánches-de-la-Torre A, et al. Precision medicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment. J Am Coll Cardiol. 2015;66(9):1023–1032.
  • Parra O, Á S-A, Capote F, et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res. 2015;24(1):47–53.
  • Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105(21):2462–2464.
  • Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670–676.
  • Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370(24):2265–2275.
  • Salord N, Fortuna AM, Monasterio C, et al. A randomized controlled trial of continuous positive airway pressure on glucose tolerance in obese patients with obstructive sleep apnea. Sleep. 2016;39:35.
  • Pamidi S, Wroblewshi K, Stepien M, et al. Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial. Am J Respir Crit Care Med. 2015;192(1):96–105.
  • Villa MP, Pagani J, Ambrosio R, et al. Mid-face hypoplasia after long-term nasal ventilation. Am J Respir Crit Care Med. 2002;166(8):1142–1143.
  • Li KK, Riley RW, Guilleminault C. An unreported risk in the use of home nasal continuous positive airway pressure and home nasal ventilation in children: mid-face hypoplasia. Chest. 2000;117(3):916–918.
  • Fauroux B, Lavis JF, Nicot F, et al. Facial side effects during noninvasive positive pressure ventilation in children. Intensive Care Med. 2005;31(7):965–969.
  • Roberts SD, Kapadia H, Greenlee G, et al. Midfacial and dental changes associated with nasal positive airway pressure in children with obstructive sleep apnea and craniofacial conditions. J Clin Sleep Med. 2016;12(4):469–475.
  • Tsuda H, Almeida FR, Tsuda T, et al. Craniofacial changes after 2 years of nasal continuous positive airway pressure use in patients with obstructive sleep apnea. Chest. 2010;138(4):870–874.
  • Guilleminault C, Akhtar F. Pediatric sleep-disordered breathing: new evidence on its development. Sleep Med Rev. 2015;24:46–56.
  • Guimaraes KC, Drager LF, Genta PR, et al. Effects of oropharyngeal exercises on patients with moderate obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2009;179(10):962–966.
  • Camacho M, Certal V, Abdullatif J, et al. Myofunctional therapy to treat obstructive sleep apnea, a systematic review and meta-analysis. Sleep. 2015;38(5):669–751.
  • Guilleminault C, Huang YS, Monteyrol PJ, et al. Critical role of myofascial reeducation in pediatric sleep-disordered breathing. Sleep Med. 2013;14:518–525.
  • Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008;5(2):173.
  • Sawyer AM, Gooneratne NS, Marcus CL, et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15(6):343–356.
  • Kohler M, Stoewhas A, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2011;184(10):1192–1199.
  • Chan ASL, Sutherland K, Schwab RJ, et al. The effect of mandibular advancement on upper airway structure in obstructive sleep apnea. Thorax. 2010;65:726–732.
  • Brown EC, Cheng S, McKenzie DK, et al. Tongue and lateral upper airway movement with mandibular advancement. Sleep. 2013;36:397–404.
  • Andren A, Hedberg P, Walker-Engstrom ML, et al. Effects of treatment with oral appliance on 24-h blood pressure in patients with obstructive sleep apnea and hypertension: a randomized clinical trial. Sleep Breath. 2013;17:705–712.
  • Petri N, Svanholt P, Solow B, et al. Mandibular advancement appliance for obstructive sleep apnoea: results of a randomized placebo controlled trial using parallel group design. J Sleep Res. 2008;17:221–229.
  • Naismith SL, Winter VR, Hickie IB, et al. Effect of oral appliance therapy on neurobehavioral functioning in obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med. 2005;1:374–380.
  • Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep. 2004;27:934–941.
  • Marklund M, Carlberg B, Forsgren L, et al. Oral appliance therapy in patients with daytime sleepiness and snoring or mild to moderate sleep apnea. JAMA Intern Med. 2015;175(8):1278–1285.
  • Heokema A, Stegnenga B, Wijkstra PJ, et al. Obstructive sleep apnea therapy. J Dent Res. 2008;87:882–887.
  • Doff MHJ, Hoekema A, Wijkstra PJ, et al. Oral appliance versus continuous positive airway pressure in obstructive sleep apnea syndrome: a 2 year follow up. Sleep. 2013;36(9):1289–1296.
  • Phillips CL, Grunstein RR, Darendeliler MA, et al. Health outcomes of CPAP versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2013;187:879–887.
  • Vanderveken OM, Dieltjens M, Wouters K, et al. Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing. Thorax. 2013;68(1):91–96.
  • El-Solh AA, Moitheennazima B, Akinnusi ME, et al. Combined oral appliance and positive airway pressure therapy for obstructive sleep apnea: a pilot study. Sleep Breath. 2011;15:203–208.
  • Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5:263–276.
  • Anandam A, Patil M, Akinnusi M, et al. Cardiovascular mortality in obstructive sleep apnea treated with continuous positive airway pressure or oral appliance: an observational study. Respirology. 2013;18:1184–1190.
  • Bratton DJ, Gaisl T, Wons AM, et al. CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a review and meta-analysis. JAMA. 2015;314:2280–2293.
  • Gagnadoux F, Fleury B, Vielle B, et al. Titrated mandibular advancement versus positive airway pressure for sleep apnoea. Eur Respir J. 2009;34:914–920.
  • Barnes M, McEvoy RD, Banks S, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170:656–664.
  • Aarab G, Lobbezoo F, Heymans MW, et al. Long-term follow-up of a randomized controlled trial of oral appliance therapy in obstructive sleep apnea. Respiration. 2011;82:162–168.
  • de Almeida FR, Lowe AA, Tsuiki S, et al. Long-term compliance and side effects of oral appliances used for the treatment of snoring and obstructive sleep apnea syndrome. J Clin Sleep Med. 2005;1:143–152.
  • Marklund M. Long-term efficacy of an oral appliance in early treated patients with obstructive sleep apnea. Sleep Breath. 2016;20:689–694.
  • Sutherland K, Vanderveken OM, Tsuda H, et al. Oral appliance treatment for obstructive sleep apnea: an update. J Clin Sleep Med. 2014;10(2):215–227.
  • Kim YK, Kim JW, Yoon IY, et al. Influencing factors on the effect of mandibular advancement device on obstructive sleep apnea patients: analysis on cephalometric and polysomnographic parameters. Sleep Breath. 2014;18(2):305–311.
  • Young T, Finn L, Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med. 2001;161(12):1514–1519.
  • Kalpaklioglu AF, Kavut AB, Ekici M. Allergic and nonallergic rhinitis: the threat for obstructive sleep apnea. Ann Allergy Asthma Immunol. 2009;103(1):20–25.
  • McNicholas WT. The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction. Eur Respir J. 2008;32(1):3–8.
  • Clarenbach CF, Kohler M, Senn O, et al. Does nasal decongestion improve obstructive sleep apnea? J Sleep Res. 2008;17(4):444–449.
  • Georgalas C. The role of the nose in snoring and obstructive sleep apnea: an update. Eur Arch Otorhinolaryngol. 2011;268:1365.
  • Virkkula P, Bachour A, Hytonen M, et al. Snoring is not relieved by nasal surgery despite improvement in nasal resistance. Chest. 2006;129(1):81–87.
  • Li H, Lee L, Wang P, et al. Nasal surgery for snoring in patients with obstructive sleep apnea. Laryngoscope. 2008;118(2):354–359.
  • Li H, Lin Y, Chen N, et al. Improvement in quality of life after nasal surgery alone for patients with obstructive sleep apnea and nasal obstruction. Arch Otolaryngol Head Neck Surg. 2008;134(4):429–433.
  • Powell NB, Zonato AI, Weaver EM, et al. Radiofrequency treatment of turbinate hypertrophy in subjects using continuous positive airway pressure: a randomized, double-blind, placebo controlled clinical pilot trial. Laryngoscope. 2011;111(10):1783–1790.
  • Yalamanchali S, Cipta S, Waxman J, et al. Effects of endoscopic sinus surgery and nasal surgery in patients with obstructive sleep apnea. Otolaryngology-Head Neck Surg. 2014;151(1):171–175.
  • Senchak AJ, McKinlay AJ, Acevedo J, et al. The effect of tonsillectomy alone in adult obstructive sleep apnea. Otolaryngology-Head Neck Surg. 2015;152(5):969–973.
  • Tan LT, tan AK, Hsu PP, et al. Effects of tonsillectomy on sleep study parameters in adult patients with obstructive sleep apnea – a prospective study. Sleep Breath. 2014;18(2):265–268.
  • Fujita S, Conway W, Zorick F, et al. Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg. 1981;89(6):923–934.
  • Smith DF, Cohen AP, Ishman SL. Surgical management of OSA in adults. Chest. 2015;147(6):1681–1690.
  • Yousuf A, Beigh Z, Khursheed RS, et al. Clinical predictors of successful uvulopalatopharyngoplasty in the management of obstructive sleep apnea. In J Otolaryngol. 2013;2013:ID290265.
  • Browaldh N, Nerfeldt P, Lysdahl M, et al. SKUP randomized controlled trial: polysomnographic results after uvulopalatopharyngoplasty in selected patients with obstructive sleep apnea. Thorax. 2013;68:846–853.
  • Mortimore IL, Bradley PA, Murray JA, et al. Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Resp Crit Care Med. 1996;154(6 pt 1):1759–1762.
  • Bettega G, Pepin JL, Veale D, et al. Obstructive sleep apnea syndrome. Fifty-one consecutive patients treated by maxillofacial surgery. Am J Respir Crit Care Med. 2000;162:641–649.
  • Holty JE, Guilleminault C. Maxillomandibular advancement for the treatment of obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev. 2010;14:287–97.
  • Li KK, Powell NB, Riley RW, et al. Long-term results of maxillomandibular advancement surgery. Sleep Breath. 2000;4:137–140.
  • Boyd SB, Walters AS, Waite P, et al. Long-term effectiveness and safety of maxillomandibular advancement for treatment of obstructive sleep apnea. J Clin Sleep Med. 2015;11(7):699–708.
  • Zaghi S, Holty JEC, Certal V, et al. Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea. JAMA Otolaryngology Head Neck Surg. 2016;142(1):58–66.
  • Lin HC, Friedman M, Chang HW, et al. The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea/hypopnea syndrome. Laryngoscope. 2008;118(5):902–908.
  • Strollo PJ, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. NEJM. 2014;370:139–149.
  • Strollo PJ, Gillespie MB, Soose RJ, et al. Upper airway stimulation for obstructive sleep apnea: durability of the treatment effect at 18 months. Sleep. 2015;38(10):1593–1598.
  • Morrell MJ, Arabi Y, Zahn B, et al. Progressive retropalatal narrowing preceding obstructive apnea. Am J Respir Crit Care Med. 1998;158(6):1974–1981.
  • Braga CW, Chen Q, Burschtin OE, et al. Changes in lung volume and upper airway using MRI during application of nasal expiratory positive airway pressure in patients with sleep-disordered breathing. J Appl Physiol. 2011;111(5):1400–1409.
  • Rosenthal L, Massie CA, Dolan DC, et al. A multicenter, prospective study of a novel nasal EPAP device in the treatment of obstructive sleep apnea: efficacy and 30-day adherence. J Clin Sleep Med. 2009;5(6):532–537.
  • Berry RB, Kryger MH, Massie CA. A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial. Sleep. 2011;34(4):479–485.
  • Schwab RJ, Kim C, Siegel L, et al. Examining the mechanism of action of a new device using oral pressure therapy for the treatment of obstructive sleep apnea. Sleep. 2014;37(7):1237–1247.
  • Colrain IM, Black J, Siegel LC, et al. A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea. Sleep Med. 2013;14(9):830–837.
  • Farid-Moayer M, Siegel LC, Black J. A feasibility evaluation of oral pressure therapy for the treatment of obstructive sleep apnea. Ther Adv Respir Dis. 2013;7(1):3–12.
  • Nigam G, Pathak C, Riaz M. Effectiveness of oral pressure therapy for obstructive sleep apnea: a systematic analysis. Sleep Breath. 2016;20:663–671.
  • Condos R, Norman RG, Krishnasamy I, et al. Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am J Respir Crit Care Med. 1994;150(2):475–480.
  • Guilleminault C, Stoohs R, Clerk A, et al. A cause of excessive daytime sleepiness: the upper airway resistance syndrome. Chest. 1993;104:781–787.
  • Palombini L, Tufik S, Rapoport D, et al. Inspiratory flow limitation in a normal population of adults in Sao Paolo, Brazil. Sleep. 2013;36:1663–1668.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.